Cargando…
Experimental Drugs for Neuropathic Pain
BACKGROUND: Neuropathic pain (NP) is an important public health problem and despite recent progress in the un-derstanding, diagnosis, pathophysiological mechanisms and the treatment of NP, many patients remain refractory to pharma-cotherapy. OBJECTIVE: Currently used drugs have limited efficacy and...
Autores principales: | Sałat, Kinga, Gryzło, Beata, Kulig, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187752/ https://www.ncbi.nlm.nih.gov/pubmed/29745335 http://dx.doi.org/10.2174/1570159X16666180510151241 |
Ejemplares similares
-
Novel Functionalized Amino Acids as Inhibitors of
GABA Transporters with Analgesic Activity
por: Gryzło, Beata, et al.
Publicado: (2021) -
Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
por: Sałat, Kinga, et al.
Publicado: (2017) -
KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain
por: Waszkielewicz, Anna, et al.
Publicado: (2022) -
The Microglial Activation Inhibitor Minocycline, Used Alone and in Combination with Duloxetine, Attenuates Pain Caused by Oxaliplatin in Mice
por: Sałat, Kinga, et al.
Publicado: (2021) -
Forebrain medial septum sustains experimental neuropathic pain
por: Ariffin, Mohammed Zacky, et al.
Publicado: (2018)